PMID- 32912249 OWN - NLM STAT- MEDLINE DCOM- 20210709 LR - 20210709 IS - 1746-1596 (Electronic) IS - 1746-1596 (Linking) VI - 15 IP - 1 DP - 2020 Sep 10 TI - Clinical study on primary screening of oral cancer and precancerous lesions by oral cytology. PG - 107 LID - 10.1186/s13000-020-01027-6 [doi] LID - 107 AB - BACKGROUND: This study was conducted to compare the histological diagnostic accuracy of conventional oral-based cytology and liquid-based cytology (LBC) methods. METHODS: Histological diagnoses of 251 cases were classified as negative (no malignancy lesion, inflammation, or mild/moderate dysplasia) and positive [severe dysplasia/carcinoma in situ (CIS) and squamous cell carcinoma (SCC)]. Cytological diagnoses were classified as negative for intraepithelial lesion or malignancy (NILM), oral low-grade squamous intraepithelial lesion (OLSIL), oral high-grade squamous intraepithelial lesion (OHSIL), or SCC. Cytological diagnostic results were compared with histology results. RESULTS: Of NILM cytology cases, the most frequent case was negative [LBC n = 50 (90.9%), conventional n = 22 (95.7%)]. Among OLSIL cytodiagnoses, the most common was negative (LBC n = 34; 75.6%, conventional n = 14; 70.0%). Among OHSIL cytodiagnoses (LBC n = 51, conventional n = 23), SCC was the most frequent (LBC n = 31; 60.8%, conventional n = 7; 30.4%). Negative cases were common (LBC n = 13; 25.5%, conventional n = 14; 60.9%). Among SCC cytodiagnoses SCC was the most common (LBC n = 16; 88.9%, conventional n = 14; 87.5%). Regarding the diagnostic results of cytology, assuming OHSIL and SCC as cytologically positive, the LBC method/conventional method showed a sensitivity of 79.4%/76.7%, specificity of 85.1%/69.2%, false-positive rate of 14.9%/30.7%, and false-negative rate of 20.6%/23.3%. CONCLUSIONS: LBC method was superior to conventional cytodiagnosis methods. It was especially superior for OLSIL and OHSIL. Because of the false-positive and false-negative cytodiagnoses, it is necessary to make a comprehensive diagnosis considering the clinical findings. FAU - Sukegawa, Shintaro AU - Sukegawa S AUID- ORCID: 0000-0001-7986-2735 AD - Department of Oral and Maxillofacial Surgery, Kagawa Prefectural Central Hospital, 1-2-1, Asahi-machi, Takamatsu, Kagawa, 760-8557, Japan. gouwan19@gmail.com. AD - Department of Oral Pathology and Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan. gouwan19@gmail.com. FAU - Ono, Sawako AU - Ono S AD - Department of Pathology, Kagawa Prefectural Central Hospital, Takamatsu, Kagawa, Japan. AD - Department of Pathology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan. FAU - Nakano, Keisuke AU - Nakano K AD - Department of Oral Pathology and Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan. FAU - Takabatake, Kiyofumi AU - Takabatake K AD - Department of Oral Pathology and Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan. FAU - Kawai, Hotaka AU - Kawai H AD - Department of Oral Pathology and Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan. FAU - Nagatsuka, Hitoshi AU - Nagatsuka H AD - Department of Oral Pathology and Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan. FAU - Furuki, Yoshihiko AU - Furuki Y AD - Department of Oral and Maxillofacial Surgery, Kagawa Prefectural Central Hospital, 1-2-1, Asahi-machi, Takamatsu, Kagawa, 760-8557, Japan. LA - eng PT - Journal Article DEP - 20200910 PL - England TA - Diagn Pathol JT - Diagnostic pathology JID - 101251558 SB - IM MH - Carcinoma in Situ/*diagnosis MH - Cross-Sectional Studies MH - Cytodiagnosis/*methods MH - Early Detection of Cancer/methods MH - Humans MH - Mouth Neoplasms/*diagnosis MH - Precancerous Conditions/*diagnosis MH - Squamous Cell Carcinoma of Head and Neck/*diagnosis PMC - PMC7488236 OTO - NOTNLM OT - Cytology OT - Inflammation OT - Liquid-based cytology OT - Pathology OT - Screening COIS- The authors declare that they have no competing interests. EDAT- 2020/09/12 06:00 MHDA- 2021/07/10 06:00 PMCR- 2020/09/10 CRDT- 2020/09/11 05:31 PHST- 2020/06/15 00:00 [received] PHST- 2020/09/04 00:00 [accepted] PHST- 2020/09/11 05:31 [entrez] PHST- 2020/09/12 06:00 [pubmed] PHST- 2021/07/10 06:00 [medline] PHST- 2020/09/10 00:00 [pmc-release] AID - 10.1186/s13000-020-01027-6 [pii] AID - 1027 [pii] AID - 10.1186/s13000-020-01027-6 [doi] PST - epublish SO - Diagn Pathol. 2020 Sep 10;15(1):107. doi: 10.1186/s13000-020-01027-6.